Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience

Nature Reviews Neuroscience

Volumn 17, Issue 7, 2016, Pages 424-437

  Mertens, Jerome ^a   Marchetto, Maria C ^a   Bardy, Cedric ^a   Gage, Fred H ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; TRANSCRIPTION FACTOR;

BRAIN CELL; CELL COUNT; CELL DIFFERENTIATION; DOPAMINERGIC NERVE CELL; EPIGENETICS; EVALUATION STUDY; FIBROBLAST; GENE REPRESSION; GENETIC VARIABILITY; GENOMICS; GLIA CELL; HUMAN; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; INTERNEURON; MACROGLIA; MOSAICISM; MOTONEURON; NERVE CELL; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NEUROSCIENCE; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANIMAL; CYTOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURAL STEM CELLS; NEURONS; NEUROSCIENCES;

EID: 84969626637     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn.2016.46     Document Type: Review

References (205)

1. Kola I, & Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3, 711-715 (2004).
2. Rubin L. L. Stem cells and drug discovery: the beginning of a new era?. Cell 132, 549-552 (2008).
3. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
4. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
5. Park I. H, et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
6. Vierbuchen T, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
7. Pang Z. P, et al. Induction of human neuronal cells by defined transcription factors. Nature 26, 220-223 (2011).
8. Xu J, Du Y, & Deng H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell 16, 119-134 (2015).
9. Prescott S. L, et al. Enhancer divergence and cis-regulatory evolution in the human and chimp neural crest. Cell 163, 68-83 (2015).
10. Marchetto M. C. N, et al. Differential L1 regulation in pluripotent stem cells of humans and apes. Nature 503, 525-529 (2013).
11. Koch P, et al. Excitation-induced ataxin 3 aggregation in neurons from patients with Machado-Joseph disease. Nature 480, 543-546 (2011).
12. Brennand K. J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225 (2011).
13. Chambers S. M, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009).
14. Maury Y, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 33, 89-96 (2014).
15. Vierbuchen T, & Wernig M. Direct lineage conversions: unnatural but useful?. Nat. Biotechnol. 29, 892-907 (2011).
16. Wichterle H, Lieberam I, Porter J. A, & Jessell T. M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397 (2002).
17. Farkas L. M, & Huttner W. B. The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development. Curr. Opin. Cell Biol. 20, 707-715 (2008).
18. Pasca S. P, et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 17, 1657-1662 (2011).
19. Fasano C. A, Chambers S. M, Lee G, Tomishima M. J, & Studer L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 6, 336-347 (2010).
20. Kriks S, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinsons disease. Nature 480, 547-551 (2011).
21. Fuccillo M, Joyner A. L, & Fishell G. Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development. Nat. Rev. Neurosci. 7, 772-783 (2006).
22. Liu A, & Niswander L. A. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat. Rev. Neurosci. 6, 945-954 (2005).
23. Ciani L, & Salinas P. C. WNTS in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 6, 351-362 (2005).
24. Mason I. Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat. Rev. Neurosci. 8, 583-596 (2007).
25. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8, 755-765 (2007).
26. Danjo T, et al. Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J. Neurosci. 31, 1919-1933 (2011).
27. Eiraku M, et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519-532 (2008).
28. Elkabetz Y, et al. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev. 22, 152-165 (2008).
29. Peljto M, & Wichterle H. Programming embryonic stem cells to neuronal subtypes. Curr. Opin. Neurobiol. 21, 43-51 (2011).
30. Yu D. X, et al. Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep. 2, 295-310 (2014).
31. Fasano C. A, et al. Bmi 1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev. 23, 561-574 (2009).
32. Maroof A. M, et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12, 559-572 (2013).
33. Nicholas C. R, et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573-586 (2013).
34. Shi Y, Kirwan P, Smith J, Robinson H. P. C, & Livesey F. J. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15, 477-486 (2012).
35. Espuny-Camacho I, et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77, 440-456 (2013).
36. Lancaster M. A, et al. Cerebral organoids model human brain development and microcephaly. Nature 510, 373-379 (2013).
37. Li X. J, et al. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 136, 4055-4063 (2009).
38. Shi Y, Kirwan P, & Livesey F. J. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat. Protoc. 7, 1836-1846 (2012).
39. Gorris R, et al. Pluripotent stem cell-derived radial glia-like cells as stable intermediate for efficient generation of human oligodendrocytes. Glia 63, 2152-2167 (2015).
40. Noctor S. C, MartInez-CerdeNo V, Ivic L, & Kriegstein A. R. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat. Neurosci. 7, 136-144 (2004).
41. Leone D. P, Srinivasan K, Chen B, Alcamo E, & McConnell S. K. The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 18, 28-35 (2008).
42. Chen B, et al. The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc. Natl Acad. Sci. USA 105, 11382-11387 (2008).
43. Alcamo E. A, et al. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57, 364-377 (2008).
44. Soldner F, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318-331 (2011).
45. Reinhardt P, et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354-367 (2013).
46. Cho M. S, Hwang D. Y, & Kim D. W. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat. Protoc. 3, 1888-1894 (2008).
47. Swistowski A, et al. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE 4, e6233 (2009).
48. Boyer L. F, Campbell B, Larkin S, Mu Y, & Gage F. H. Dopaminergic differentiation of human pluripotent cells. Curr. Protoc. Stem Cell Biol. http://.dx.doi.org/10.1002/9780470151808.sc01h06s22 (2012).
49. Ganat Y. M, et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J. Clin. Invest. 122, 2928-2939 (2012).
50. Arlotta P, et al. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207-221 (2005).
51. Molyneaux B. J, Arlotta P, Menezes J. R. L, & Macklis J. D. Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427-437 (2007).
52. Lodato S, et al. Gene co regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons. Nat. Neurosci. 17, 1046-1054 (2014).
53. Ruby K. M, & Zheng B. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 27, 1496-1506 (2009).
54. Di Giorgio F. P, Boulting G. L, Bobrowicz S, & Eggan K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637-648 (2008).
55. Marchetto M. C. N, et al. Non-cell-Autonomous effect of human SOD1. Cell Stem Cell 3, 649-657 (2008).
56. Dimos J. T, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221 (2008).
57. Amoroso M. W, et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J. Neurosci. 33, 574-586 (2013).
58. Ebert A. D, & Svendsen C. N. Stem cell model of spinal muscular atrophy. Arch. Neurol. 67, 665-669 (2010).
59. Ng S. Y, et al. Genome-wide RNA-Seq of human motor neurons implicates selective ER stress activation in spinal muscular atrophy. Cell Stem Cell 17, 569-584 (2015).
60. Egawa N, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl Med. 4, 145ra104 (2012).
61. Wonders C. P, & Anderson S. A. The origin and specification of cortical interneurons. Nat. Rev. Neurosci. 7, 687-696 (2006).
62. Chao H. T, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263-269 (2010).
63. Lewis D. A, Curley A. A, Glausier J. R, & Volk D. W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35, 57-67 (2012).
64. Glass C. K, Saijo K, Winner B, Marchetto M. C, & Gage F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934 (2010).
65. Verkhratsky A, & Parpura V. Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders. Neurobiol. Dis. 85, 254-261 (2016).
66. Eroglu C, & Barres B. A. Regulation of synaptic connectivity by glia. Nature 468, 223-231 (2010).
67. Chung W. S, Allen N. J, & Eroglu C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harbor Perspect. Biol. 7, a020370 (2015).
68. Krencik R, Weick J. P, Liu Y, Zhang Z. J, & Zhang S. C. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 29, 528-534 (2011).
69. Krencik R, & Zhang S. C. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 6, 1710-1717 (2011).
70. Zhang P. W, et al. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology. Glia 64, 63-75 (2015).
71. Pfeiffer S. E, Warrington A. E, & Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3, 191-197 (1993).
72. Rogister B, Ben-Hur T, & Dubois-Dalcq M. From neural stem cells to myelinating oligodendrocytes. Mol. Cell. Neurosci. 14, 287-300 (1999).
73. Grinspan J. Cells and signaling in oligodendrocyte development. J. Neuropathol. Exp. Neurol. 61, 297-306 (2002).
74. Schachner M, Kim S. K, & Zehnle R. Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies. Dev. Biol. 83, 328-338 (1981).
75. Douvaras P, & Fossati V. Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nat. Protoc. 10, 1143-1154 (2015).
76. Kerman B. E, et al. In vitro myelin formation using embryonic stem cells. Development 142, 2213-2225 (2015).
77. Hu B. Y, Du Z. W, Li X. J, Ayala M, & Zhang S. C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443-1452 (2009).
78. Johansson J. U, et al. Prostaglandin signaling suppresses beneficial microglial function in Alzheimers disease models. J. Clin. Invest. 125, 350-364 (2015).
79. Zhong Z, et al. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 119, 3437-3449 (2009).
80. De Boer A. S, et al. Genetic validation of a therapeutic target in a mouse model of ALS. Sci. Transl Med. 6, 248ra104 (2014).
81. Crotti A, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat. Neurosci. 17, 513-521 (2014).
82. Nayak D, Roth T. L, & McGavern D. B. Microglia development and function. Annu. Rev. Immunol. 32, 367-402 (2014).
83. Tabar V, & Studer L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat. Rev. Genet. 15, 82-92 (2014).
84. Lassar A. B, Paterson B. M, & Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47, 649-656 (1986).
85. Davis R. L, Weintraub H, & Lassar A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 (1987).
86. Berninger B, et al. Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J. Neurosci. 27, 8654-8664 (2007).
87. Heinrich C, et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 8, e1000373 (2010).
88. Son E. Y, et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9, 205-218 (2011).
89. Pfisterer U, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl Acad. Sci. USA 108, 10343-10348 (2011).
90. Chambers S. M, & Studer L. Cell fate plug and play: direct reprogramming and induced pluripotency. Cell 145, 827-830 (2011).
91. Yang N, Ng Y. H, Pang Z. P, Südhof T. C, & Wernig M. Induced neuronal cells: how to make and define a neuron. Cell Stem Cell 9, 517-525 (2011).
92. Iwafuchi-Doi M, & Zaret K. S. Pioneer transcription factors in cell reprogramming. Genes Dev. 28, 2679-2692 (2014).
93. Soufi A, Donahue G, & Zaret K. S. Facilitators and impediments of the pluripotency reprogramming factors initial engagement with the genome. Cell 151, 994-1004 (2012).
94. Soufi A, et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015).
95. Wapinski O. L, et al. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell 155, 621-635 (2013).
96. Castro D. S, & Guillemot F. Old and new functions of proneural factors revealed by the genome-wide characterization of their transcriptional targets. Cell Cycle 10, 4026-4031 (2011).
97. Marro S, et al. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell 9, 374-382 (2011).
98. Liu M. L, et al. Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat. Commun. 4, 2183 (2013).
99. Vadodaria K. C, et al. Generation of functional human serotonergic neurons from. Mol. Psychiatry 21, 49-61 (2015).
100. Lau S, Ottosson D. R, Jakobsson J, & Parmar M. Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors. Cell Rep. 9, 1673-1680 (2014).
101. Sun Y, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104, 365-376 (2001).
102. Ladewig J, et al. Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat. Methods 9, 575-578 (2012).
103. Zhao P, Zhu T, Lu X, Zhu J, & Li L. Neurogenin 2 enhances the generation of patient-specific induced neuronal cells. Brain Res. 1615, 51-60 (2015).
104. Masserdotti G, et al. Transcriptional mechanisms of proneural factors and REST in regulating neuronal reprogramming of astrocytes. Cell Stem Cell 17, 74-88 (2015).
105. Pollak J, et al. ASCL1 reprograms mouse Müller glia into neurogenic retinal progenitors. Development 140, 2619-2631 (2013).
106. Fishman V. S, et al. Cell divisions are not essential for the direct conversion of fibroblasts into neuronal cells. Cell Cycle 14, 1188-1196 (2015).
107. Sun C. K, et al. Senescence impairs direct conversion of human somatic cells to neurons. Nat. Commun. 5, 4112 (2014).
108. Yoo A. S, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476, 228-231 (2011).
109. Ambasudhan R, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 9, 113-118 (2011).
110. Xue Y, et al. Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell 152, 82-96 (2013).
111. Lunyak V. V, & Rosenfeld M. G. No rest for REST: REST/NRSF regulation of neurogenesis. Cell 121, 499-501 (2005).
112. Ballas N, & Mandel G. The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15, 500-506 (2005).
113. Li X, et al. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 17, 195-203 (2015).
114. Hu W, et al. Direct conversion of normal and Alzheimers disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell 17, 204-212 (2015).
115. Petrik D, et al. Functional and mechanistic exploration of an adult neurogenesis-promoting small molecule. FASEB J. 26, 3148-3162 (2012).
116. Edri R, et al. Analysing human neural stem cell ontogeny by consecutive isolation of Notch active neural progenitors. Nat. Commun. 6, 6500 (2015).
117. Stott S. R. W, et al. Foxa1 and Foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages. J. Neurosci. 33, 8022-8034 (2013).
118. Andersson E, et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124, 393-405 (2006).
119. Caiazzo M, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476, 224-227 (2012).
120. Liu X, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 22, 321-332 (2011).
121. Kiyasova V, & Gaspar P. Development of raphe serotonin neurons from specification to guidance. Eur. J. Neurosci. 34, 1553-1562 (2011).
122. Xu Z, et al. Direct conversion of human fibroblasts to induced serotonergic neurons. Mol. Psychiatry 21, 62-70 (2015).
123. Victor M. B, et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 84, 311-323 (2014).
124. Blanchard J. W, et al. Selective conversion of fibroblasts into peripheral sensory neurons. Nat. Neurosci. 18, 25-35 (2014).
125. Caiazzo M, et al. Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. Stem Cell Rep. 4, 25-36 (2015).
126. Yang N, et al. Generation of oligodendroglial cells by direct lineage conversion. Nat. Biotechnol. 31, 434-439 (2013).
127. Najm F. J, et al. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat. Biotechnol. 31, 426-433 (2013).
128. Mitchell R. R, et al. Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT 4. Stem Cells Dev. 23, 1937-1946 (2014).
129. Polo J. M, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151 1617-1632 (2012).
130. Thier M, et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10, 473-479 (2012).
131. Meyer S, Wörsdörfer P, Günther K, Thier M, & Edenhofer F. Derivation of adult human fibroblasts and their direct conversion into expandable neural progenitor cells. J. Vis. Exp. 101, e52831 (2015).
132. Ring K. L, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100-109 (2012).
133. Lujan E, Chanda S, Ahlenius H, Südhof T. C, & Wernig M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl Acad. Sci. USA 109, 2527-2532 (2012).
134. Han D. W, et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10, 465-472 (2012).
135. Kim Y. J, et al. Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor. Cell Stem Cell 15, 497-506 (2014).
136. Yu K. R, et al. Rapid and efficient direct conversion of human adult somatic cells into neural stem cells by HMGA2/let 7b. Cell Rep. 10, 441-452 (2015).
137. Margariti A, Kelaini S, & Cochrane A. Direct reprogramming of adult cells: avoiding the pluripotent state. Stem Cells Cloning 7, 19-29 (2014).
138. Aasen T, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284 (2008).
139. Griesi-Oliveira K, et al. Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons. Mol. Psychiatry 20, 1350-1365 (2014).
140. Tamaoki N, et al. Dental pulp cells for induced pluripotent stem cell banking. J. Dent. Res. 89, 773-778 (2010).
141. Chou B. K, et al. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med. 4, 320-332 (2015).
142. Giorgetti A, et al. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat. Protoc. 5, 811-820 (2010).
143. Seki T, et al. Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells. PLoS ONE 9, e85645 (2014).
144. Zhou T, et al. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 7, 2080-2089 (2012).
145. Cassady J. P, et al. Direct lineage conversion of adult mouse liver cells and B lymphocytes to neural stem cells. Stem Cell Rep. 3, 948-956 (2014).
146. Addis R. C, et al. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS ONE 6, e28719 (2011).
147. Karow M, et al. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 11, 471-476 (2012).
148. Yang Y, et al. Direct conversion of adipocyte progenitors into functional neurons. Cell. Reprogram. 15, 484-489 (2013).
149. Chanda S, et al. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep. 3, 282-296 (2014).
150. Zhang Y, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785-798 (2013).
151. Thoma E. C, et al. Ectopic expression of neurogenin 2 alone is sufficient to induce differentiation of embryonic stem cells into mature neurons. PLoS ONE 7, e38651 (2012).
152. Bissonnette C. J, et al. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells 29, 802-811 (2011).
153. Theka I, et al. Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. Stem Cells Transl Med. 2, 473-479 (2013).
154. Mong J, et al. Transcription factor-induced lineage programming of noradrenaline and motor neurons from embryonic stem cells. Stem Cells 32, 609-622 (2014).
155. Kim H. J, et al. REST regulates non-cell-Autonomous neuronal differentiation and maturation of neural progenitor cells via secretogranin II. J. Neurosci. 35, 14872-14884 (2015).
156. Koch P, Opitz T, Steinbeck J. A, Ladewig J, & Brüstle O. A rosette-Type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc. Natl Acad. Sci. USA 106, 3225-3230 (2009).
157. Falk A, et al. Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons. PLoS ONE 7, e29597 (2012).
158. Chen Q, Fischer A, Reagan J. D, Yan L. J, & Ames B. N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl Acad. Sci. USA 92, 4337-4341 (1995).
159. Mertens J, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 527, 95-99 (2015).
160. Burkhardt M. F, et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 56, 355-364 (2013).
161. Israel M. A, et al. Probing sporadic and familial Alzheimers disease using induced pluripotent stem cells. Nature 482, 216-220 (2012).
162. Maherali N, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
163. Meissner A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770 (2008).
164. Guenther M. G, et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249-257 (2010).
165. Suhr S. T, et al. Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5, e14095 (2010).
166. Prigione A, et al. Mitochondrial-Associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived ips cells harboring chromosomal aberrations. PLoS ONE 6, e27352 (2011).
167. Bershteyn M, et al. Cell-Autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 507, 99-103 (2014).
168. Rando T. A, & Chang H. Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46-57 (2012).
169. Lapasset L, et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248-2253 (2011).
170. Miller J. D, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691-705 (2013).
171. Frobel J, et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep. 3, 414-422 (2014).
172. Studer L, Vera E, & Cornacchia D. Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell 16, 591-600 (2015).
173. Yang Y, et al. Enhanced rejuvenation in induced pluripotent stem cell-derived neurons compared with directly converted neurons from an aged mouse. Stem Cells Dev. 24, 2767-2777 (2015).
174. Mertens J, et al. Directly reprogrammed human neurons retain aging-Associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17, 705-718 (2015).
175. Ziller M. J, et al. Dissecting neural differentiation regulatory networks through epigenetic footprinting. Nature 518, 355-359 (2015).
176. Lee G, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406 (2010).
177. Marchetto M. C. N, et al. A model for neural developmentand treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143 527-539 (2010).
178. Samaco R. C, Hogart A, & LaSalle J. M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483-492 (2005).
179. Rapoport J. L, Giedd J. N, & Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 17, 1228-1238 (2012).
180. Sanches M, Keshavan M. S, Brambilla P, & Soares J. C. Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1617-1627 (2008).
181. Konopka G, et al. Modeling the functional genomics of autism using human neurons. Mol. Psychiatry 17, 202-214 (2011).
182. Abyzov A, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442 (2012).
183. McConnell M. J, et al. Mosaic copy number variation in human neurons. Science 342, 632-637 (2013).
184. Varela C, et al. Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J. Clin. Invest. 122, 569-574 (2012).
185. Pasi C. E, et al. Genomic instability in induced stem cells. Cell Death Differ. 18, 745-753 (2011).
186. Sun Y, et al. Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat. Mater. 13, 599-604 (2014).
187. Bardy C, et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl Acad. Sci. USA 112, e2725-e2734 (2015).
188. Fatehullah A, Tan S. H, & Barker N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246-254 (2016).
189. Passier R, Orlova V, & Mummery C. Complex tissue and disease modeling using hiPSCs. Cell Stem Cell 18, 309-321 (2016).
190. Thomson J. A, et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
191. Lewis T. L. Jr, Courchet J, & Polleux F. Cellular and molecular mechanisms underlying axon formation, growth, and branching. J. Cell Biol. 202, 837-848 (2013).
192. Berg D. A, Belnoue L, Song H, & Simon A. Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain. Development 140, 2548-2561 (2013).
193. Choquet D, & Triller A. The dynamic synapse. Neuron 80, 691-703 (2013).
194. Ding B, et al. Temporal regulation of nuclear factor one occupancy by calcineurin/NFAT governs a voltage-sensitive developmental switch in late maturing neurons. J. Neurosci. 33, 2860-2872 (2013).
195. Okazawa M, et al. Role of calcineurin signaling in membrane potential-regulated maturation of cerebellar granule cells. J. Neurosci. 29, 2938-2947 (2009).
196. Colasante G, et al. rapid conversion of fibroblasts into functional forebrain GABAergic interneurons by direct genetic reprogramming. Cell Stem Cell 17, 719-734 (2015).
197. Hu K. Vectorology and factor delivery in induced pluripotent stem cell reprogramming. Stem Cells Dev. 23, 1301-1315 (2014).
198. Sommer C. A, & Mostoslavsky G. Experimental approaches for the generation of induced pluripotent stem cells. Stem Cell Res. Ther. 1, 26 (2010).
199. Um S. H. Delivering factors for reprogramming a somatic cell to pluripotency. Int. J. Stem Cells 5, 6-11 (2012).
200. Adler A. F, et al. Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol. Ther. Nucleic Acids 1, e32 (2012).
201. Shi Z, & Jiao J. Direct lineage conversion: induced neuronal cells and induced neural stem cells. Protein Cell 3, 826-833 (2012).
202. Garitaonandia I, et al. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLoS ONE 10, e0118307 (2015).
203. Umegaki-Arao N, et al. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa. Sci. Transl Med. 6, 264ra164 (2014).
204. Folmes C. D. L, et al. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells 31, 1298-1308 (2013).
205. Brennand K, et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20, 361-368 (2015).